Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation

Metabolism: Clinical and Experimental

Volumn 60, Issue 4, 2011, Pages 513-522

  Tomizawa, Atsuko ^a   Hattori, Yoshiyuki ^a   Inoue, Teruo ^a   Hattori, Sachiko ^a   Kasai, Kikuo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BEZAFIBRATE; COMPOUND C; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PIRINIXIC ACID; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRAIN HEPG2; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; BEZAFIBRATE; BLOTTING, WESTERN; CAPILLARIES; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FENOFIBRATE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEPATOCYTES; HUMANS; HYPERGLYCEMIA; HYPOLIPIDEMIC AGENTS; I-KAPPA B KINASE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; VASCULITIS;

EID: 79952986434     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.04.020     Document Type: Article

References (28)

1. Keech A., Simes R.J., Barter P., Best J., Scott R., and Taskinen M.R. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial Lancet 366 2005 1849 1861
2. Keech A.C., Mitchell P., Summanen P.A., O'Day J., Davis T.M., and Moffitt M.S. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial Lancet 370 2007 1687 1697 (Pubitemid 350100775)
3. Wierzbicki A.S. Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia Curr Opin Cardiol 24 2009 372 379
4. Rajamani K., Colman P.G., Li L.P., Best J.D., Voysey M., and D'Emden M.C. Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial Lancet 373 2009 1780 1788
5. Ido Y., Carling D., and Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation Diabetes 51 2002 159 167 (Pubitemid 34517993)
6. Cacicedo J.M., Yagihashi N., Keaney J.F. Jr, Ruderman N.B., and Ido Y. AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells Biochem Biophys Res Commun 324 2004 1204 1209 (Pubitemid 40292150)
7. Murakami H., Murakami R., Kambe F., Cao X., Takahashi R., and Asai T. Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC Biochem Biophys Res Commun 341 2006 973 978 (Pubitemid 43221761)
8. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., and Wu M. Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108 2001 1167 1174 (Pubitemid 32995375)
9. Fryer L.G., Parbu-Patel A., and Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J Biol Chem 277 2002 25226 25232 (Pubitemid 34951829)
10. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., and Uchida S. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nature Medicine 8 2002 1288 1295 (Pubitemid 35373562)
11. Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Muller C., and Carling D. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase Nature 415 2002 339 343 (Pubitemid 34087557)
12. Hattori Y., Suzuki M., Hattori S., and Kasai K. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells Diabetologia 46 2003 1543 1549 (Pubitemid 37518575)
13. Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum Proc Natl Acad Sci U S A 86 1989 9030 9033 (Pubitemid 20010361)
14. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-Felmayer G., and Werner E.R. l-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin J Biol Chem 276 2001 40 47 (Pubitemid 32050286)
15. Hattori Y., Suzuki M., Hattori S., and Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts) Hypertension 39 2002 22 28 (Pubitemid 34098083)
16. Kamata H., Manabe T., Oka S., Kamata K., and Hirata H. Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops FEBS Lett 519 2002 231 237 (Pubitemid 34522025)
17. Yamagishi S., Inagaki Y., Okamoto T., Amano S., Koga K., and Takeuchi M. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells J Biol Chem 277 2002 20309 20315 (Pubitemid 34967325)
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 1983 55 63 (Pubitemid 14203433)
19. Pepper C., Thomas A., Tucker H., Hoy T., and Bentley P. Flow cytometric assessment of three different methods for the measurement of in vitro apoptosis Leuk Res 22 1998 439 444 (Pubitemid 28279130)
20. Vermes I., Haanen C., and Reutelingsperger C. Flow cytometry of apoptotic cell death J Immunol Methods 243 2000 167 190
21. Schulz E., Schuhmacher S., and Münzel T. When metabolism rules perfusion: AMPK-mediated endothelial nitric oxide synthase activation Circ Res 104 2009 422 424
22. Hardie D.G. The AMP-activated protein kinase pathway-new players upstream and downstream J Cell Sci 117 2004 5479 5487 (Pubitemid 40012195)
23. Dagher Z., Ruderman N., Tornheim K., and Ido Y. Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells Circ Res 88 2001 1276 1282 (Pubitemid 32587844)
24. Giri S., Nath N., Smith B., Viollet B., Singh A.K., and Singh I. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase J Neurosci 24 2004 479 487 (Pubitemid 38112379)
25. Hattori Y., Suzuki K., Hattori S., and Kasai K. Metformin inhibits cytokine-induced NF-kB activation via AMPK activation in vascular endothelial cells Hypertension 47 2006 1183 1188 (Pubitemid 44289177)
26. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., and Abe Y. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin Circ Res 94 2004 e27 e31
27. Ho F.M., Lin W.W., Chen B.C., Chao C.M., Yang C.R., and Lin L.Y. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway Cell Signal 18 2006 391 399 (Pubitemid 41661354)
28. Leal E.C., Aveleira C.A., Castilho A.F., Serra A.M., Baptista F.I., and Hosoya K. High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspase-independent pathway Exp Eye Res 88 2009 983 991